A Study to Assess the Efficacy and Safety of RO7790121 for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Summary
- Eligibility
- for people ages 16-80 (full criteria)
- Location
- at UC Irvine UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hoffmann-La Roche
- ID
- NCT06589986
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 400 study participants
- Last Updated